Terms: = Sarcomas AND OLIG2, OLIGO2, 10215, ENSG00000205927, BHLHB1, RACK17, PRKCBP2 AND Treatment
2 results:
1. olig2 is a marker of the fusion protein-driven neurodevelopmental transcriptional signature in alveolar rhabdomyosarcoma.
Raghavan SS; Mooney KL; Folpe AL; Charville GW
Hum Pathol; 2019 Sep; 91():77-85. PubMed ID: 31299267
[TBL] [Abstract] [Full Text] [Related]
2. Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study.
Izycka-Swieszewska E; Bien E; Stefanowicz J; Szurowska E; Szutowicz-Zielinska E; Koczkowska M; Sigorski D; Kloc W; Rogowski W; Adamkiewicz-Drozynska E
Biomed Res Int; 2018; 2018():4596812. PubMed ID: 29805974
[TBL] [Abstract] [Full Text] [Related]
